Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Plaque Psoriasis”

531 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 531 results

Post-approval studies (Phase 4)Ended earlyNCT00972543
What this trial is testing

Raptiva in Palm and Sole Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Merck KGaA, Darmstadt, Germany 6
Not applicableStudy completedNCT04433442
What this trial is testing

Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis

Who this might be right for
PsoriasisPsoriatic Arthritis
AbbVie 2,324
Testing effectiveness (Phase 2)Ended earlyNCT02201524
What this trial is testing

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Pfizer 59
Post-approval studies (Phase 4)Study completedNCT00932113
What this trial is testing

Mechanism of Action Study for Psoriasis

Who this might be right for
Psoriasis
Tufts Medical Center 33
Early research (Phase 1)UnknownNCT02918123
What this trial is testing

Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Kang Stem Biotech Co., Ltd. 9
Large-scale testing (Phase 3)Active Not RecruitingNCT06846541
What this trial is testing

Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasis (PsO)Psoriasis+2 more
Alumis Inc 1,680
Testing effectiveness (Phase 2)Study completedNCT04718896
What this trial is testing

Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
UCB Biopharma SRL 41
Not applicableStudy completedNCT00678470
What this trial is testing

Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis

Who this might be right for
Moderate to Severe Psoriasis
University of California, San Francisco 18
Not applicableWithdrawnNCT01758705
What this trial is testing

Post Marketing Observational Study on Venezuelan Patients With Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
AbbVie (prior sponsor, Abbott)
Large-scale testing (Phase 3)Study completedNCT02074982
What this trial is testing

Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Type Psoriasis
Novartis Pharmaceuticals 676
Post-approval studies (Phase 4)Study completedNCT04571567
What this trial is testing

Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Saakshi Khattri 20
Large-scale testing (Phase 3)Study completedNCT03390101
What this trial is testing

An International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Biocad 213
Testing effectiveness (Phase 2)Study completedNCT02905006
What this trial is testing

Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma S.P.R.L. 250
Large-scale testing (Phase 3)Study completedNCT00679731
What this trial is testing

Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie (prior sponsor, Abbott) 317
Early research (Phase 1)Study completedNCT03058744
What this trial is testing

Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 94
Large-scale testing (Phase 3)Study completedNCT00747344
What this trial is testing

Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 121
Testing effectiveness (Phase 2)Study completedNCT04172233
What this trial is testing

A Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Akeso 96
Large-scale testing (Phase 3)Study completedNCT02207244
What this trial is testing

Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 992
Large-scale testing (Phase 3)Ended earlyNCT02786732
What this trial is testing

Study to Evaluate Broadlumab vs Placebo and Ustekinumab

Who this might be right for
Psoriasis
MedDerm Associates 15
Large-scale testing (Phase 3)Study completedNCT03066609
What this trial is testing

Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 543
Load More Results